TIBOR KELER Insider Trading
Get free email notifications about insider trading for TIBOR KELER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of TIBOR KELER. TIBOR KELER is an Executive VP & CSO in Celldex Therapeutics, Inc. ($AVAN) and a Sr. VP & CSO in Celldex Therapeutics, Inc. ($AVAN).
Address: 30 PARK ROAD OTTSVILLE 18942 PA
Companies in which TIBOR KELER is an Insider
Celldex Therapeutics, Inc.
Trading Symbol: CLDXIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of TIBOR KELER: Executive VP & CSO, Sr. VP & CSO
Holdings: 7,357 shares
Latest Transaction: Jun 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of TIBOR KELER
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 19 2020 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Option Exercise | A | 10.38 | 108,000 | 1,121,040 | 108,000 | |
Jun 10 2020 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Buy | P | 2.99 | 5,000 | 14,954 | 7,357 | 2.4 K to 7.4 K (+212.13 %) |
Jun 20 2019 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Option Exercise | A | 2.78 | 60,000 | 166,800 | 60,000 | |
Jun 18 2018 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Buy | P | 0.59 | 16,500 | 9,783 | 35,368 | 18.9 K to 35.4 K (+87.45 %) |
Jun 15 2018 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Option Exercise | A | 0.60 | 390,000 | 234,429 | 390,000 | |
Jun 16 2017 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Option Exercise | A | 2.32 | 162,000 | 375,840 | 162,000 | |
Sep 06 2016 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Buy | P | 3.32 | 3,000 | 9,960 | 18,868 | 15.9 K to 18.9 K (+18.91 %) |